Searched for
DABIGATRAN
Fresh tailwinds emerge as government comes in again with intent: 7 pharma stocks with upside potential of up to 36%Budget 2026 underlines the government’s intent – in terms of the sectors it will focus on. Now, it is not all of a sudden that the governme...- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of more than 26% in 1 yearThe way things have panned out in the last few weeks clearly indicates that there is a higher probability of the market staying bullish. Th...
- Ignore noise on the street, stick to basics: 5 stocks from different sectors with an upside potential of up to 38%The markets are volatile with a bearish bias, and the Nifty and Sensex are bearing the brunt. A closer look, however, reveals that, even in...
- Alembic gets USFDA nod for generic medicationAlembic Pharmaceuticals announced approval from the USFDA to market Dabigatran Etexilate Capsules (110 mg) for deep vein thrombosis prophyl...
- Alembic Pharma gets USFDA nod for Dabigatran Etexilate capsulesAlembic Pharmaceuticals Ltd received final approval from the US health regulator for generic Dabigatran Etexilate capsules 75 mg and 150 mg...
- Getting back into shape? 6 Indian pharma stocks with upside potential of up to 41%The year 2024, started with a correction in nifty, but one set of stocks which were able to outperform were pharma stocks. While it might a...
- These largecaps have ‘strong buy’ & ‘buy’ recos and upside potential of more than 20%In the last few weeks, the range in which the nifty had been moving has become broader as the volatility has increased both due to internat...
- These largecaps have ‘strong buy’ & ‘buy’ recos and upside scope of over 20%As the market moves from clearly bullish mode to volatile mode with a bearish bias, there will be readjustment in valuation across markets....
- These largecaps have ‘strong buy’ & ‘buy’ recos and upside potential of more than 20%While the correction has been going on in the market since the middle of July, it is only on days like Monday where everyone on the street ...
- Nifty healthcare index stocks; Staying bullish on select pharma and hospitalsWhile they clubbed together, the operating matrix of a pharma company making drugs and hospital and a diagnostic company are very different...
- Nifty healthcare index stocks analysts suggest buying have potential upside of more than 19%Except for a pocket in which demand for covid drugs led to sharp surge in pharma stocks, the pharma sector had been under pressure for a lo...
- These largecaps have ‘Strong Buy’ & ‘Buy’ reco and upside potential of more than 25%As the NIFTY and broader market recovers, analysts are bullish on select large cap stock. Making to the list are a host of companies from d...
- Should you stick to largecaps amid volatile Nifty? These 4 stocks have up to 30% upside scopeAs volatility increases, the focus in the market is shifting to stocks which are considered as relatively defensive. These stocks tend to f...
- A consistent wealth creator among 11 stocks that have an upside potential of over 25%As the market witnesses volatile movement there are few large cap stocks which are still finding favor with analysts. After the recent corr...
- Anti-diabetes drugs and patented antivirals to get cheaper, NLEM notifiedFor the first time, patented drugs like anti-TB bedaquiline and delamanid, anti-HIV Dolutegravir and anti-hepatitis C daclatasvir are also ...
- Diabetes, patented TB, HIV drugs enter essential listPopular anti-diabetes drug teneligliptin, insulin glargine injection, Common antibiotics like meropenem, Cefuroxime have been included in t...
- Essential medicines list: Govt adds 34 new drugs, drops 26; all you need to knowSeveral anti-cancer drugs, antibiotics and vaccines will now become more affordable as they are among 34 new additions to the National List...
- Market falls for 3rd day in a row; Sensex down 575 pts; Nifty drops below 17,650The back-to-back selloff came as investors digested the implications of a hawkish Federal Reserve and awaited the outcome of RBI's monetary...
- Alembic Pharma gets tentative USFDA nod for generic version of Dabigatran Etexilate capsulesThe tentatively approved ANDA is therapeutically equivalent to the reference listed drug (RLD) product Pradaxa Capsules, 75 mg, 110 mg, and...
- Natco Pharma launches anti blood clot medication, Rivaroxaban, in IndiaRivaroxaban is an anticoagulant medication used to treat and prevent blood clots. The medication is currently sold by Bayer under the brand...
Load More
